Whitehawk Therapeutics WHWK
NASDAQ WHWK
$4.60 -0.03 (-0.65%)
As of: Sep 4, 2026 · 3:59 PM EDT

Whitehawk Therapeutics (WHWK) Non Operating Interest Expenses (2010 - 2024)

Analysis

Whitehawk Therapeutics (WHWK) Non Operating Interest Expenses (2010 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 23.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 93.62 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 20.27 Mn
10 Whitehawk Therapeutics 377.13 Mn 377.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 38,000.00
Jun 30, 2024 58,000.00
Mar 31, 2024 58,000.00
Dec 31, 2023 57,000.00
Sep 30, 2023 58,000.00
Jun 30, 2023 58,000.00
Mar 31, 2023 58,000.00
Dec 31, 2022 57,000.00
Sep 30, 2022 58,000.00
Jun 30, 2022 58,000.00
Mar 31, 2022 58,000.00
Dec 31, 2021 57,000.00
Sep 30, 2021 157,000.00
Jun 30, 2021 227,000.00
Mar 31, 2021 224,000.00
Dec 31, 2020 230,000.00
Sep 30, 2020 229,000.00
Dec 31, 2016 2,571.00
Sep 30, 2016 2,434.00
Jun 30, 2016 2,543.00